Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

Let’s set the table for Sunday’s presentation of the lung cancer immunotherapy trial known as HARMONi-2. Last June, Summit Therapeutics created a lot of buzz — and sent its stock surging ...

Investors will be looking to see if Merck’s 2023 revenue results meet or beat the outlook it issued last quarter of $59.7B to $60.2B. Analysts, on average, are expecting $59.94B for 2023. For ...

The following resources are intended to provide professional development opportunities for the total Army. As we remain committed to an all-volunteer Army that is the most decisive land force in ...

Merck will be releasing earnings for the most recent quarter on August 1. Analysts expect Merck will report earnings per share of €2.05. Go here to watch Merck stock price in real-time on ...

Richard Staines presents a preview of the likely movers and shakers ... with a first analysis from its phase 3 CheckMate-227 trial. Merck’s Keytruda (pembrolizumab) is the leader in this use ...

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care ...

What’s next for Akeso and Summit Therapeutics after their cancer immunotherapy outperformed Merck’s Keytruda in a large Phase 3 clinical trial? Who’s the iconoclastic outsider behind Summit ...

That’s still true, but the Pro line is only marginally better now, and to make a case for itself, Apple has had to target the Pro line at actual professionals. To start with the basics: because the ...

An Industry Player's Expected Results Among the stocks in the Zacks Large Cap Pharmaceuticals industry, Merck (MRK) is soon expected to post earnings of $1.94 per share for the quarter ended ...

Courtesy of Google The Pixel 9 Pro also comes with all the new AI features and apps available on the rest of the Pixel 9 range, which you can read about in the Pixel 9 preview, and their standard ...

Merck & Co.’s best-selling drug Keytruda helped women with a hard-to-treat form of breast cancer live longer, according to the first study to show such a benefit in these patients. After five ...